HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical study of [123I] N-(2-diethylaminoethyl)-4-iodobenzamide in the diagnosis of primary and metastatic ocular melanoma.

AbstractPURPOSE:
To assess the value of scintigraphy with [123I]N-(2-diethylaminoethyl)-4-iodobenzamide (BZA), a phase II clinical trial was performed on 48 patients with a suspicion of ocular melanoma.
METHODS:
56 examinations were performed to image lesions with a clinical diagnosis of primary ocular melanoma before and/or after treatment, to observe the results in simulating lesions or to image metastases.
RESULTS:
Ocular BZA-scintigraphy demonstrated a sensitivity of 86%, and a specificity of 83%. Whole-body scintigraphy was used in the follow-up of treated patients and could be repeated. We imaged orbital recurrence, known and occult metastases, specially in the liver. After 9 conservative treatments ocular BZA-scintigraphy was negative in 9 eyes.
CONCLUSION:
The BZA-scintigraphy in combination with other diagnostic procedures appeared to be a suitable method in the diagnosis of ocular melanoma and a potentially useful imaging modality to screen for ocular malignant melanoma metastases.
AuthorsF Bacin, J Michelot, J Bonafous, A Veyre, M F Moreau, J L Kemeny, F Chossat, D Bekhechi
JournalActa ophthalmologica Scandinavica (Acta Ophthalmol Scand) Vol. 76 Issue 1 Pg. 56-61 (Feb 1998) ISSN: 1395-3907 [Print] Denmark
PMID9541435 (Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article)
Chemical References
  • Benzamides
  • Contrast Media
  • N-(2-(diethylamino)ethyl)-4-iodobenzamide
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Benzamides
  • Brachytherapy
  • Conjunctival Neoplasms (diagnostic imaging, pathology, therapy)
  • Contrast Media
  • Eye Enucleation
  • Female
  • Humans
  • Laser Coagulation
  • Liver Neoplasms (diagnostic imaging, secondary, therapy)
  • Lung Neoplasms (diagnostic imaging, secondary, therapy)
  • Male
  • Melanoma (diagnostic imaging, secondary, therapy)
  • Middle Aged
  • Radionuclide Imaging
  • Sensitivity and Specificity
  • Uveal Neoplasms (diagnostic imaging, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: